Managing the Risks of Agentic AI in Global Health Care Organizations: A Governance Perspective
Academy of Management Proceedings · 2026-07 · 2026 (1)
DOI: 10.5465/amproc.2026.19129poster ↗Kurz gefasst
Fachartikel in der Zeitschrift Academy of Management Proceedings, 2026-07. Verfasst von Ricky Leung.
Abstract (Originalsprache)
The rapid emergence of agentic artificial intelligence (AI)—systems capable of initiating actions and coordinating tasks across organizational settings—creates new governance and risk management challenges for health care organizations worldwide. Although AI adoption in health care is expanding across diverse national contexts, existing research has largely focused on technical performance and implementation within single organizations. These approaches provide limited guidance for managers and policymakers confronting the system-level risks associated with agentic AI operating across organizational and jurisdictional boundaries. This poster presents a macro organizational perspective on agentic AI grounded in governance, risk management, and interorganizational network theory. We conceptualize agentic AI as a coordinating infrastructure that extends organizational action beyond formal boundaries and redistributes responsibility among health care organizations, technology vendors, and public agencies across different regulatory environments. From a governance standpoint, we argue that organization-specific oversight mechanisms are insufficient for managing AI systems that act continuously across multiple sites of care. From a risk perspective, agentic AI generates shared and cascading operational, reputational, and equity-related risks that require collective monitoring and coordination. Practice implications are emphasized. For health care leaders, the findings highlight the need to move beyond isolated AI governance toward network-level risk management, including shared standards, cross-organizational incident reporting, and clearly defined accountability across partners. For policymakers and regulators, the analysis underscores the importance of coordinating oversight across sectors and jurisdictions to address AI-enabled risks that no single organization can manage alone. For technology vendors, the framework points to the necessity of aligning product design with health system governance requirements and equity goals. Together, these implications provide actionable guidance for managing agentic AI safely, equitably, and responsibly in global health care systems.
Zitieren
APA
Leung, R. (2026). Managing the Risks of Agentic AI in Global Health Care Organizations: A Governance Perspective. Academy of Management Proceedings, 2026(1). https://doi.org/10.5465/amproc.2026.19129poster
Vancouver
Leung R. Managing the Risks of Agentic AI in Global Health Care Organizations: A Governance Perspective. Academy of Management Proceedings. 2026;2026(1). doi:10.5465/amproc.2026.19129poster
BibTeX
@article{Leung2026,
author = {Leung, Ricky},
title = {Managing the Risks of Agentic AI in Global Health Care Organizations: A Governance Perspective},
journal = {Academy of Management Proceedings},
year = {2026},
volume = {2026},
number = {1},
doi = {10.5465/amproc.2026.19129poster}
}
EUVIMED